These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 206626)

  • 41. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency.
    Mohana Subramanian B; Madhanmohan M; Sriraman R; Chandrasekhar Reddy RV; Yuvaraj S; Manikumar K; Rajalakshmi S; Nagendrakumar SB; Rana SK; Srinivasan VA
    Antiviral Res; 2012 Dec; 96(3):288-95. PubMed ID: 23043941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The serological response against foot and mouth disease virus elicited by repeated vaccination of dairy cattle.
    Elnekave E; Dekker A; Eble P; van Hemert-Kluitenberg F; Gelman B; Storm N; Klement E
    Vaccine; 2016 Sep; 34(41):4920-4926. PubMed ID: 27576078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental infections using the foot-and-mouth disease virus O/JPN/2010 in animals administered a vaccine preserved for emergency use in Japan.
    Fukai K; Nishi T; Shimada N; Morioka K; Yamada M; Yoshida K; Sakamoto K; Kitano R; Yamazoe R; Yamakawa M
    J Vet Med Sci; 2017 Jan; 79(1):128-136. PubMed ID: 27773883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle.
    Barrera J; Brake DA; Kamicker BJ; Purcell C; Kaptur R; Schieber T; Lechtenberg K; Miller TD; Ettyreddy D; Brough DE; Butman BT; Colby M; Neilan JG
    Transbound Emerg Dis; 2018 Apr; 65(2):447-455. PubMed ID: 29076657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The suitability of the 'emergency' foot-and-mouth disease antigens held by the International Vaccine Bank within a global context.
    Barnett PV; Samuel AR; Statham RJ
    Vaccine; 2001 Feb; 19(15-16):2107-17. PubMed ID: 11228383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunologic responses in Dutch cattle vaccinated with foot-and-mouth disease vaccines under field conditions: neutralizing antibody responses to O, A, and C types.
    Fish RC; van Bekkum JG; Lehmann RP; Richardson GV
    Am J Vet Res; 1969 Dec; 30(12):2115-23. PubMed ID: 5389418
    [No Abstract]   [Full Text] [Related]  

  • 47. Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina.
    Maradei E; La Torre J; Robiolo B; Esteves J; Seki C; Pedemonte A; Iglesias M; D'Aloia R; Mattion N
    Vaccine; 2008 Dec; 26(51):6577-86. PubMed ID: 18835312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protection of cattle against foot-and-mouth disease by a synthetic peptide.
    DiMarchi R; Brooke G; Gale C; Cracknell V; Doel T; Mowat N
    Science; 1986 May; 232(4750):639-41. PubMed ID: 3008333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Presence of antibodies to non-structural proteins of foot-and-mouth disease virus in repeatedly vaccinated cattle.
    Lee F; Jong MH; Yang DW
    Vet Microbiol; 2006 Jun; 115(1-3):14-20. PubMed ID: 16446061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation of virus-infection-associated (VIA) antigen of foot-and-mouth disease (FMD) virus from inactivated vaccine.
    Sugimura T; Tsuda T; Suzuki T; Murakami Y
    J Vet Med Sci; 1996 Jun; 58(6):599-601. PubMed ID: 8811637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serological comparison of a type sat 2 foot-and-mouth disease virus isolate from Sudan with other type SAT 2 strains.
    Abu Elzein EM; Crowther JR
    Bull Anim Health Prod Afr; 1979 Dec; 27(4):245-8. PubMed ID: 232850
    [No Abstract]   [Full Text] [Related]  

  • 52. Identification of foot-and-mouth disease virus-specific linear B-cell epitopes to differentiate between infected and vaccinated cattle.
    Höhlich BJ; Wiesmüller KH; Schlapp T; Haas B; Pfaff E; Saalmüller A
    J Virol; 2003 Aug; 77(16):8633-9. PubMed ID: 12885881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaccination against foot and mouth disease reduces virus transmission in groups of calves.
    Orsel K; Dekker A; Bouma A; Stegeman JA; de Jong MC
    Vaccine; 2005 Sep; 23(41):4887-94. PubMed ID: 16002192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease.
    Mattion N; König G; Seki C; Smitsaart E; Maradei E; Robiolo B; Duffy S; León E; Piccone M; Sadir A; Bottini R; Cosentino B; Falczuk A; Maresca R; Periolo O; Bellinzoni R; Espinoza A; Torre JL; Palma EL
    Vaccine; 2004 Oct; 22(31-32):4149-62. PubMed ID: 15474705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines.
    Morgan DO; Moore DM
    Am J Vet Res; 1990 Jan; 51(1):40-5. PubMed ID: 2154148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emergence of antigenic variants with in serotype A foot and mouth disease virus in India and evaluation of a new vaccine candidate panel.
    Rudreshappa AG; Sanyal A; Mohapatra JK; Subramaniam S; De A; Das B; Singanallur NB; Jangam AK; Muthukrishnan M; Villuppanoor SA; Pattnaik B
    Vet Microbiol; 2012 Aug; 158(3-4):405-9. PubMed ID: 22445197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies I: Benefits of Higher Potency Vaccines and Associated NSP DIVA Test Systems in Post-Outbreak Surveillance.
    Barnett PV; Geale DW; Clarke G; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):367-87. PubMed ID: 24112127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancement of immunizing potency of a foot-and-mouth disease vaccine for cattle by treatment of the antigen with formaldehyde.
    Mowat GN; Masters RC; Prince MJ
    Arch Gesamte Virusforsch; 1973; 41(4):365-70. PubMed ID: 4354238
    [No Abstract]   [Full Text] [Related]  

  • 59. [Use of anti-foot-and-mouth disease vaccine in oil adjuvant in young cattle].
    Brun A; Chappuis G; Favre H; Roulet C; Terré J
    Dev Biol Stand; 1976; 35():117-22. PubMed ID: 198277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Determination of effectiveness of FMD vaccine type Asia 1 in neutralization tests in cattle].
    Dimitriadis IA
    Berl Munch Tierarztl Wochenschr; 1993 Apr; 106(4):124-7. PubMed ID: 8387775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.